Clinical interests focus on acute leukemias and stem cell transplantation.
Research is early phase (1 and 2) trials combining with signal transduction inhibitors with chemotherapy for the treatment of acute leukemias and MDS.
The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement.
